These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12531416)

  • 1. Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing.
    Pohwani AL; Murali S; Mathier MM; Tokarczyk T; Kormos RL; McNamara DM; MacGowan GA
    J Heart Lung Transplant; 2003 Jan; 22(1):78-86. PubMed ID: 12531416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers.
    Peterson LR; Schechtman KB; Ewald GA; Geltman EM; de las Fuentes L; Meyer T; Krekeler P; Moore ML; Rogers JG
    J Heart Lung Transplant; 2003 Oct; 22(10):1141-8. PubMed ID: 14550824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure.
    Peterson LR; Schechtman KB; Ewald GA; Geltman EM; Meyer T; Krekeler P; Rogers JG
    J Heart Lung Transplant; 2003 Jan; 22(1):70-7. PubMed ID: 12531415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers.
    Shakar SF; Lowes BD; Lindenfeld J; Zolty R; Simon M; Robertson AD; Bristow MR; Wolfel EE
    J Card Fail; 2004 Feb; 10(1):15-20. PubMed ID: 14966770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers.
    O'Neill JO; Young JB; Pothier CE; Lauer MS
    Circulation; 2005 May; 111(18):2313-8. PubMed ID: 15867168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.
    Koelling TM; Joseph S; Aaronson KD
    J Heart Lung Transplant; 2004 Dec; 23(12):1414-22. PubMed ID: 15607672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
    Tabet JY; Metra M; Thabut G; Logeart D; Cohen-Solal A
    Am J Cardiol; 2006 Aug; 98(4):500-3. PubMed ID: 16893705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
    Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
    Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption.
    Cattadori G; Agostoni P; Corrà U; Di Lenarda A; Sinagra G; Veglia F; Salvioni E; La Gioia R; Scardovi AB; Emdin M; Metra M; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Mezzani A; Scrutinio D; Pacileo G; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Giannuzzi P; Battaia E; Cicoira M; Passino C; Piepoli MF;
    Int J Cardiol; 2013 Oct; 168(5):5078-81. PubMed ID: 23962781
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart rate reduction and exercise performance in recent onset heart failure with reduced ejection fraction: arguments for beta-blocker hypo-response.
    Verbrugge FH; Vrijsen J; Vercammen J; Grieten L; Dupont M; Mullens W
    Acta Cardiol; 2015 Oct; 70(5):565-72. PubMed ID: 26567816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-blocker therapy on functional status in patients with heart failure--a meta-analysis.
    Abdulla J; Køber L; Christensen E; Torp-Pedersen C
    Eur J Heart Fail; 2006 Aug; 8(5):522-31. PubMed ID: 16376611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: possible impact in clinical decision-making?
    Ciolac EG; Bocchi EA; Fernandes da Silva MM; Tavares AC; Teixeira-Neto IS; Guimarães GV
    Cardiol J; 2013; 20(6):655-61. PubMed ID: 24338544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.
    Kato TS; Collado E; Khawaja T; Kawano Y; Kim M; Farr M; Mancini DM; Schulze PC
    Circ Heart Fail; 2013 Jan; 6(1):6-14. PubMed ID: 23204059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is exercise training beneficial for heart failure patients taking β-adrenergic blockers? A systematic review and meta-analysis.
    Ismail H; McFarlane J; Smart NA
    Congest Heart Fail; 2013; 19(2):61-9. PubMed ID: 22958534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.
    Lund LH; Aaronson KD; Mancini DM
    Am J Cardiol; 2005 Mar; 95(6):734-41. PubMed ID: 15757599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation.
    Methvin A; Georgiopoulou VV; Kalogeropoulos AP; Malik A; Anarado P; Chowdhury M; Hussain I; Book WM; Laskar SR; Vega JD; Smith AL; Butler J
    Am J Cardiol; 2010 May; 105(9):1353-5. PubMed ID: 20403492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.
    Campodonico J; Piepoli M; Clemenza F; Bonomi A; Paolillo S; Salvioni E; Corrà U; Binno S; Veglia F; Lagioia R; Sinagra G; Cattadori G; Scardovi AB; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Magrì D; Parati G; Re F; Cicoira M; Minà C; Limongelli G; Correale M; Frigerio M; Bussotti M; Perna E; Battaia E; Guazzi M; Badagliacca R; Di Lenarda A; Maggioni A; Passino C; Sciomer S; Pacileo G; Mapelli M; Vignati C; Lombardi C; Filardi PP; Agostoni P;
    Int J Cardiol; 2018 Dec; 273():141-146. PubMed ID: 30098827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the cardiopulmonary exercise test in patients with heart failure who have been treated with beta-blockers.
    Dufay-Bougon C; Belin A; Dahdouh ZS; Barthelemy S; Mabire JP; Sabatier R; Milliez P; Grollier G
    Turk Kardiyol Dern Ars; 2013 Mar; 41(2):105-12. PubMed ID: 23666296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.
    Witte KK; Cleland JG; Clark AL
    Heart; 2006 Apr; 92(4):481-6. PubMed ID: 16159968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.